Harvard Bioscience names new CFO
Photo | Google
Harvard Bioscience's Holliston headquarters on October Hill Road.
Harvard Bioscience has appointed biotech finance veteran Kam Unninayar to replace the departed Robert Gagnon.
She will take over the Holliston company's finances beginning Nov. 26.
Unninayar brings more than two decades of global finance leadership at public companies, including as CFO of Tetraphase, Inc. of Watertown, and more than 11 years in finance roles at Thermo Fisher Scientific in Waltham.
At Thermo Fisher, Unninayar served as vice president of finance of several of the company’s businesses with revenues ranging from $200 million to $4 billion.
Before that, Unninayar held finance roles at Fortune 500 consumer companies.
Unninayar, boasting a master of science in administration from Wichita State University and a master of finance and control and bachelor of commerce from the University of Delhi, India, will take over the company’s finance as it attempts to transition to profitability.
Harvard Bioscience last reported second-quarter earnings in August, including revenues of $31.5 million, a 66-percent increase over the same period a year ago. Gagnon resigned shortly after to take a position at another company.
For the year, the company's revenue was up 57 percent to $58.3 million, but profitability has eluded the company, which lost $5.5 million over the first six months of 2018.
The company reported a net loss in each of the last three years but has made improvements in reducing that loss. In 2015, the company reported losing $19 million and lost just $865,000 in 2017.
The company is expected to announce its third-quarter results on Thursday.
WBJ Web Partners
Most Recent
Most Recent
0 Comments